文献速递冠心病血脂与心血管预防

核受体Dax1通过抑制脂质转运和巨噬细胞自噬促进动脉粥样硬化

Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages.
PubMed 文献 · Eur Heart J · 2025-01-01

该研究探讨核受体Dax1在动脉粥样硬化中的作用及靶向干预策略。在动脉粥样硬化动脉中Dax1 mRNA在核受体中上调,巨噬细胞特异性Dax1敲除小鼠动脉粥样硬化减轻。机制上Dax1抑制LXRα并直接结合TFEB抑制自噬,导致巨噬细胞脂质蓄积和炎症;2'-脱氧胞苷浓度依赖性降低Dax1、增强自噬、减少脂质蓄积并抑制小鼠动脉粥样硬化。

要点

  • 动脉粥样硬化斑块中Dax1在巨噬细胞升高,巨噬细胞Dax1敲除减轻动脉粥样硬化。
  • Dax1通过抑制LXRα脂质转运和结合TFEB抑制自噬促斑块形成。
  • 2'-脱氧胞苷可降低Dax1并抑制小鼠动脉粥样硬化。

核心结论

  • Dax1在动脉粥样硬化斑块中升高,通过抑制TFEB介导的自噬和抑制LXRα脂质转运促进巨噬细胞脂质蓄积与炎症,从而促进动脉粥样硬化。
  • Dax1是动脉粥样硬化的潜在治疗靶点,2'-脱氧胞苷靶向Dax1可抑制小鼠动脉粥样硬化。

研究设计与样本

  • 检测人动脉粥样硬化动脉中Dax1水平。
  • 建立巨噬细胞特异性Dax1敲低小鼠(AAV8-PCSK9给药)及巨噬细胞Dax1与ApoE双敲除小鼠动脉粥样硬化模型。
  • 采用转录组和蛋白质组分析解析机制,并用Dax1抑制剂2'-脱氧胞苷在巨噬细胞和小鼠中验证。

主要发现

  • 与人非动脉粥样硬化动脉相比,动脉粥样硬化动脉中Dax1 mRNA在核受体中上调,且在斑块巨噬细胞中升高明显。
  • 巨噬细胞特异性Dax1敲除小鼠动脉粥样硬化较对照减轻。
  • 机制上Dax1抑制LXRα,并直接结合TFEB抑制自噬,导致巨噬细胞脂质蓄积和炎症。
  • 2'-脱氧胞苷浓度依赖性降低Dax1水平、增强自噬、减少脂质蓄积并抑制小鼠动脉粥样硬化。

临床怎么用

  • Dax1可作为动脉粥样硬化防治的潜在新靶点。
  • 2'-脱氧胞苷靶向Dax1抑制动脉粥样硬化的效果尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Nuclear receptors (NRs) are involved in cardiovascular physiology and pathology. Dosage-sensitive sex reversal, adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (Dax1) is a co-repressor of several protective NRs. However, whether Dax1 influences atherosclerosis remains unclear. This study aims to explore the role of Dax1 in atherogenesis and find a pharmacological approach targeting Dax1 to prevent atherosclerosis. METHODS: Dax1 levels were examined in human atherosclerotic arteries. Atherosclerosis animal models were established in mice with macrophage-specific Dax1 knockdown following AAV8-PCSK9 administration and double knockout of macrophage Dax1 and ApoE to evaluate the role of Dax1. Transcriptomic and proteomic analyses were employed to decipher the underlying mechanisms. 2'-Deoxycytidine, an inhibitor of Dax1, was used to verify the effects of Dax1 in macrophages and in mice with atherosclerosis. RESULTS: Dax1 mRNA level was up-regulated among NRs in atherosclerotic arteries compared to non-atherosclerotic arteries. The elevation of Dax1 was prominent in the macrophages of atherosclerotic arteries. Macrophage-specific Dax1 knockout mice had less atherosclerosis than controls. Mechanistically, Dax1 inhibited liver X receptor alpha (LXRα), and interacted directly with transcription factor EB (TFEB) to suppress autophagy, resulting in lipid accumulation and inflammation in macrophages. Additionally, 2'-deoxycytidine concentration dependently decreased Dax1 levels, enhanced autophagy, reduced lipid accumulation, and inhibited atherosclerosis in mice. CONCLUSIONS: This study demonstrates that Dax1 levels are increased in atherosclerotic plaques. Dax1 promotes atherosclerosis by interacting with TFEB to suppress autophagy and inhibiting LXRα for lipid transport in macrophage, indicating that Dax1 is a potential target for atherosclerosis.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Li F, Wang Y, Chen S, et al. Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages. Eur Heart J. 2025. PMID: 40259807. doi:10.1093/eurheartj/ehaf241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。